Parotid Tumors Market Research Report - Forecast to 2027

Parotid Tumors Market Information: By Type (Pleomorphic Adenoma) By Treatment (Removal Of Lymph Node, Radiation Therapy, Chemotherapy) By Diagnosis (Ct Scan, Ultrasound, Sialography) And End Users (Hospitals, Specialty Centers) Global Forecast Till 2027

ID: MRFR/Pharma/4223-HCR | | Region: Global | 105 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Parotid Tumors are abnormal growth within the salivary gland. The parotid glands are prone to various conditions like fibrous reaction, parotitis, salivary stones, injury, cancers, and parotid tumors. The parotid tumor can be cancerous or non-cancerous.


Parotid Tumors can be caused by various reasons such as certain abdominal surgery, liver cirrhosis, dehydration, salivary gland infections, metastasis of cancer, and salivary duct stones.


The global parotid tumors market is majorly driven by growing prevalence of cancer, growing liver cirrhosis, and rising consumption of alcohol. Additionally, factors such as government initiatives and support, rising demand for advanced technologies and growing market players offering newer products are likely to drive the market.


According to Cancer Research U.K, around 14.1 million cases of cancer were diagnosed in 2014. Additionally, according to national cancer institute in 2014, around 14.5 million cases of cancer went undiagnosed. Such statistics has propelled the overall number of cancer cases and thereby are likely to drive the growth of global parotid tumors market.


Factors that are likely to hamper the growth of the market are the complications that will arise after the needed treatment.


Global Parotid Tumors market is expected to grow at a CAGR of 7.1% during the forecasted period.


Figure: Global Parotid Tumors Market, by Region, 2017 (%)


 Parotid Tumors Market


Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, market research future analysis, annual report, white paper, company presentation


Intended Audience



  • Pharmaceutical Manufacturers and Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology:


 Parotid Tumors Market Research Methodology


Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, market research future analysis, annual report, white paper, company presentation


Segments 


The global Parotid Tumors infection market is segmented on the basis of type, treatment, diagnosis and end users.


By the type Pleomorphic Adenoma, Warthin's Tumor and Cancerous/Malignant Tumor. 


On the basis of treatment, the market is segmented into Parotidectomy, Removal of Lymph Node, Reconstructive Surgery, Radiation Therapy, and Chemotherapy.


 By diagnosis, the market is segmented into X-ray, CT scan, MRI, Ultrasound, FNAC (Fine Needle Aspiration Cytology), Sialography, and others. 


On the basis of the end users, the market is segmented into hospitals, Specialty centers, and Research centers.


Regional Analysis


North America Parotid Tumors market is a growing market in the Americas region. On a regional basis, Americas region is segmented into North America and South America. North America is segmented into US and Canada. Increasing number of cancer and rising consumption of alcohol among the masses is likely to drive the growth of North America Parotid Tumors market. Additionally, rising healthcare expenditure is likely to drive the growth of the market. For instance, according to National Institute on alcohol abuse and alcoholism, in 2015, around 26.9% individuals aged 18 and above are engaged in drinking.Similarly, according to Agency for Healthcare Research and Quality (AHRQ), around USD 80.2 billion was spent in cancer treatment.


Europe is the second largest market and holds a noticeable share in the global Parotid Tumors market. The European market is expected to grow a healthy growth during the forecast period owing to the availability of newer and advanced treatment facilities, and rising skilled medical professionals along with growing need for better healthcare infrastructure. Furthermore, extensive research and development activities for the treatment of disease and increasing government support and initiative boost the market growth.  


Asia Pacific is expected to be the fastest growing market. Increasing prevalence of chronic diseases is the major driver for the market growth. India is the fastest growing region owing to an increasing population. Rising awareness about the health and availability of new treatment methods drive the market in this region. Rising healthcare expenditure and overall growth of healthcare diagnostic and treatment industry also drive the market.


The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, United Arab Emirates is the largest market share owing to the development of healthcare industry and rising availability of specialty care centers.


Key Players                                                                                                         


Some of the players in the Parotid Tumors market are Eli Lilly & Co, Bayer AG, Merck & Co. Inc., Pfizer Inc., Bristol-Myers Squibb, Janssen Global Services, LLC, Hoffmann-La Roche Ltd, and Novartis AG.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   7.1% (2017-2023
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Treatment, Diagnosis, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Eli Lilly & Co, Bayer AG, Merck & Co. Inc., Pfizer Inc., Bristol-Myers Squibb, Janssen Global Services, LLC, Hoffmann-La Roche Ltd, and Novartis AG.
  Key Market Opportunities   Growing market players offering newer products
  Key Market Drivers

  • Growing prevalence of cancer
  • Growing liver cirrhosis
  • Rising consumption of alcohol
  • Government initiatives and support
  • Rising demand for advanced technologies


  • Table of Content


    1. Report Prologue

    2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    6. Global Parotid Tumors Market, by Type

    6.1 Introduction

    6.2 Pleomorphic Adenoma

    6.2.1 Market Estimates & Forecast, 2020-2027

    6.3 Warthin's Tumor

    6.3.1 Market Estimates & Forecast, 2020-2027

    6.4 Cancerous/Malignant Tumor

    6.4.1 Market Estimates & Forecast, 2020-2027

    7. Global Parotid Tumors Market, by Diagnosis

    7.1 Introduction

    7.2 X-Ray

    7.2.1 Market Estimates & Forecast, 2020-2027

    7.3 CT Scan

    7.3.1 Market Estimates & Forecast, 2020-2027

    7.4 MRI

    7.4.1 Market Estimates & Forecast, 2020-2027

    7.5 Ultrasound

    7.5.1 Market Estimates & Forecast, 2020-2027

    7.6 FNAC (Fine Needle Aspiration Cytology)

    7.6.1 Market Estimates & Forecast, 2020-2027

    7.7 Sialography

    7.7.1 Market Estimates & Forecast, 2020-2027

    7.8 Others

    7.8.1 Market Estimates & Forecast, 2020-2027

    8. Global Parotid Tumors Market, by Treatment

    8.1 Introduction

    8.2 Parotidectomy

    8.2.1 Market Estimates & Forecast, 2020-2027

    8.3 Removal of Lymph Node

    8.3.1 Market Estimates & Forecast, 2020-2027

    8.4 Reconstructive Surgery

    8.4.1 Market Estimates & Forecast, 2020-2027

    8.5 Radiation Therapy

    8.5.1 Market Estimates & Forecast, 2020-2027

    8.6.1 Market Estimates & Forecast, 2020-2027

    9. Global Parotid Tumors Market, by End User

    9.1 Introduction

    9.2 Hospitals

    9.2.1 Market Estimates & Forecast, 2020-2027

    9.3 Specialty centers

    9.3.1 Market Estimates & Forecast, 2020-2027

    9.4 Research centers

    9.4.1 Market Estimates & Forecast, 2020-2027

    10 Global Parotid Tumors Market, by Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 U.S.

    10.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 U.K.

    10.3.1.4 Italy

    10.3.1.5 Spain

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 Republic of Korea

    10.4.6 Rest of Asia Pacific

    10.5 The Middle East & Africa

    10.5.1 United Arab Emirates

    10.5.2 Saudi Arabia

    10.5.3 Oman

    10.5.4 Kuwait

    10.5.5 Qatar

    10.5.6 Rest of the Middle East & Africa

    11 Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    11.3.1 Key Developments

    12 Company Profiles

    12.1 Eli lilly & Co

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials

    12.1.4 SWOT Analysis

    12.2 Bayer AG

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 Merck & Co. Inc.

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Pfizer Inc.

    12.4.1 Company Overview

    12.4.2 Product/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Bristol-Myers Squibb

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.6 Janssen Global Services, LLC

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.7 Hoffmann-La Roche Ltd

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financials

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 Others

    13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View Point

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Prediction of Pharmaceutical Industry

    14 Appendix

    LIST OF TABLES

    Table 1 Parotid Tumors Industry Synopsis, 2020-2027

    Table 2 Global Parotid Tumors Market Estimates and Forecast, 2020-2027, (USD Million)

    Table 3 Global Parotid Tumors Market by Region, 2020-2027, (USD Million)

    Table 5 Global Parotid Tumors Market by Treatment, 2020-2027, (USD Million)

    Table 6 Global Parotid Tumors Market by Diagnosis, 2020-2027, (USD Million)

    Table 7 Global Parotid Tumors Market by End Users, 2020-2027, (USD Million)

    Table 8 North America Parotid Tumors Market by Treatment, 2020-2027, (USD Million)

    Table 9 North America Parotid Tumors Market by Daignosis, 2020-2027, (USD Million)

    Table 10 North America Parotid Tumors Market by End Users, 2020-2027, (USD Million)

    Table 11 US Parotid Tumors Market by Treatment, 2020-2027, (USD Million)

    Table 12 US Parotid Tumors Market by Daignosis, 2020-2027, (USD Million)

    Table 13 US Parotid Tumors Market by End Users, 2020-2027, (USD Million)

    Table 14 Canada Parotid Tumors Market by Treatment, 2020-2027, (USD Million)

    Table 15 Canada Parotid Tumors Market by Daignosis, 2020-2027, (USD Million)

    Table 16 Canada Parotid Tumors Market by End Users, 2020-2027, (USD Million)

    Table 17 South America Parotid Tumors Market by Treatment, 2020-2027, (USD Million)

    Table 18 South America Parotid Tumors Market by Diagnosis, 2020-2027, (USD Million)

    Table 19 South America Parotid Tumors Market by End Users, 2020-2027, (USD Million)

    Table 20 Europe Parotid Tumors Market by Treatment, 2020-2027, (USD Million)

    Table 21 Europe Parotid Tumors Market by Diagnosis, 2020-2027, (USD Million)

    Table 22 Europe Parotid Tumors Market by End Users, 2020-2027, (USD Million)

    Table 23 Western Europe Parotid Tumors Market by Treatment, 2020-2027, (USD Million)

    Table 24 Western Europe Parotid Tumors Market by diagnosis, 2020-2027, (USD Million)

    Table 25 Western Europe Parotid Tumors Market by End Users, 2020-2027, (USD Million)

    Table 26 Eastern Europe Parotid Tumors Market by Treatment, 2020-2027, (USD Million)

    Table 27 Eastern Europe Parotid Tumors Market by diagnosis, 2020-2027, (USD Million)

    Table 28 Eastern Europe Parotid Tumors Market by End Users, 2020-2027, (USD Million)

    Table 29 Asia Pacific Parotid Tumors Market by Treatment, 2020-2027, (USD Million)

    Table 30 Asia Pacific Parotid Tumors Market by diagnosis, 2020-2027, (USD Million)

    Table 31 Asia Pacific Parotid Tumors Market by End Users, 2020-2027, (USD Million)

    Table 32 Middle East & Africa Parotid Tumors Market by Treatment, 2020-2027, (USD Million)

    Table 33 Middle East & Africa Parotid Tumors Market by diagnoses, 2020-2027, (USD Million)

    Table 34 Middle East & Africa Parotid Tumors Market by End Users, 2020-2027, (USD Million)


    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Parotid Tumors Market

    Figure 3 Segmentation Market Dynamics for Parotid Tumors Market

    Figure 4 Global Parotid Tumors Market Share, by Treatment 2020

    Figure 5 Global Parotid Tumors Market Share, by Diagnosis 2020

    Figure 6 Global Parotid Tumors Market Share, by End Users, 2020

    Figure 7 Global Parotid Tumors Market Share, by Region, 2020

    Figure 8 North America Parotid Tumors Market Share, by Country, 2020

    Figure 9 Europe Parotid Tumors Market Share, by Country, 2020

    Figure 10 Asia Pacific Parotid Tumors Market Share, by Country, 2020

    Figure 11 Middle East & Africa Parotid Tumors Market Share, by Country, 2020

    Figure 12 Global Parotid Tumors Market: Company Share Analysis, 2020 (%)

    Figure 13 Bayer AG: Key Financials

    Figure 14 Bayer AG: Segmental Revenue

    Figure 16 Bayer AG: Geographical Revenue

    Figure 17 Pfizer Inc.: Key Financials

    Figure 18 Pfizer Inc.: Segmental Revenue

    Figure 19 Pfizer Inc.: Geographical Revenue

    Figure 20 Hoffmann-La Roche Ltd: Key Financials

    Figure 21 Hoffmann-La Roche Ltd: Segmental Revenue

    Figure 22 Hoffmann-La Roche Ltd: Geographical Revenue

    Figure 23 Novartis AG: Key Financials

    Figure 24 Novartis AG: Segmental Revenue

    Figure 25 Novartis AG: Geographical Revenue

    Figure 26 AstraZeneca: Key Financials

    Figure 27 AstraZeneca: Segmental Revenue

    Figure 28 AstraZeneca: Geographical Revenue

    Figure 29 Amgen: Key Financials

    Figure 30 Amgen: Segmental Revenue

    Figure 31 Amgen: Geographical Revenue

    Figure 32 Johnson & Johnson: Key Financials

    Figure 33 Johnson & Johnson: Segmental Revenue

    Figure 34 Johnson & Johnson: Geographical Revenue